198 related articles for article (PubMed ID: 36506837)
1. In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales.
Lu G; Tang H; Xia Z; Yang W; Xu H; Liu Z; Ni S; Wang Z; Shen J
Infect Drug Resist; 2022; 15():7107-7116. PubMed ID: 36506837
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
3. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant
Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q
Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934
[TBL] [Abstract][Full Text] [Related]
4. In vitro effectiveness of ceftazidime-avibactam in combination with aztreonam on carbapenemase-producing Enterobacterales.
Romina PE; Lucía A; Leticia C; Federica F; Pablo Á; Verónica S; Antonio G; Inés B; Rafael V
J Glob Antimicrob Resist; 2023 Dec; 35():62-66. PubMed ID: 37611893
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
Bianco G; Boattini M; Comini S; Casale R; Iannaccone M; Cavallo R; Costa C
Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):573-580. PubMed ID: 35061145
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates.
Lim TP; Ho JY; Teo JQ; Sim JH; Tan SH; Tan TT; Kwa AL
Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764002
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms.
Khan A; Erickson SG; Pettaway C; Arias CA; Miller WR; Bhatti MM
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0084621. PubMed ID: 34424044
[TBL] [Abstract][Full Text] [Related]
8. Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from
Pragasam AK; Veeraraghavan B; Shankar BA; Bakthavatchalam YD; Mathuram A; George B; Chacko B; Korula P; Anandan S
Indian J Med Microbiol; 2019; 37(1):34-41. PubMed ID: 31424008
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
[TBL] [Abstract][Full Text] [Related]
10. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects.
Bianco G; Boattini M; Comini S; Iannaccone M; Bondi A; Cavallo R; Costa C
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):63-70. PubMed ID: 34462816
[TBL] [Abstract][Full Text] [Related]
12. In vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenem-resistant
Zou C; Wei J; Shan B; Chen X; Wang D; Niu S
Infect Drug Resist; 2020; 13():3563-3568. PubMed ID: 33116675
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test.
Harris H; Tao L; Jacobs EB; Bergman Y; Adebayo A; Tekle T; Lewis S; Dahlquist A; Abbey TC; Wenzler E; Humphries R; Simner PJ
J Clin Microbiol; 2023 May; 61(5):e0164722. PubMed ID: 37070979
[TBL] [Abstract][Full Text] [Related]
14. Rapid characterization of carbapenem-resistant Enterobacterales by multiplex lateral flow assay and detection of ceftazidime-avibactam-aztreonam synergy.
Kalaivani R; Kali A; Surendran R; Sujaritha T; Ganesh Babu CP
Indian J Med Microbiol; 2024; 47():100530. PubMed ID: 38246242
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018.
Kiratisin P; Kazmierczak K; Stone GG
J Glob Antimicrob Resist; 2021 Dec; 27():132-141. PubMed ID: 34478880
[TBL] [Abstract][Full Text] [Related]
16. Genetic Diversity and in vitro Activity of Aztreonam/Avibactam and Ceftazidime/Avibactam Against Carbapenem-Resistant
Sun S; Chen K; Kong X; Tian W; Niu S
Infect Drug Resist; 2022; 15():2243-2251. PubMed ID: 35510161
[TBL] [Abstract][Full Text] [Related]
17. Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant
Li X; Quan J; Ke H; Wu W; Feng Y; Yu Y; Jiang Y
Front Microbiol; 2021; 12():724272. PubMed ID: 34484166
[TBL] [Abstract][Full Text] [Related]
18. Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience.
Bianco G; Boattini M; Iannaccone M; Bondi A; Ghibaudo D; Zanotto E; Peradotto M; Cavallo R; Costa C
J Glob Antimicrob Resist; 2021 Mar; 24():411-414. PubMed ID: 33621692
[TBL] [Abstract][Full Text] [Related]
19. In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing
Kuai J; Zhang Y; Lu B; Chen H; Zhang Y; Li H; Wang Y; Wang Q; Wang H; Wang X
Infect Drug Resist; 2023; 16():3171-3182. PubMed ID: 37249967
[TBL] [Abstract][Full Text] [Related]
20. Characteristic of KPC-12, a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in the Carbapenem-Resistant
Han W; Zhou P; Chen C; Wu C; Shen L; Wan C; Xiao Y; Zhang J; Wang B; Shi J; Yuan X; Gao H; Wang H; Zhou Y; Yu F
Infect Drug Resist; 2024; 17():2541-2554. PubMed ID: 38933778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
